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Objective In previous cases, we have observed
occasional hypoglycaemic episodes in preterm infants
after initial intensive care. In this prospective study, we
determined the frequency and severity of abnormal
tissue glucose (TG) in clinically stable preterm infants on
full enteral nutrition.
Methods Preterm infants born at <1000 g (n=23; G1)
and birth weight 1000–1500 g (n=18; G2) were studied
at a postmenstrual age of 32±2 weeks (G1) and 33
±2 weeks (G2). Infants were fed two or three hourly,
according to a standard bolus-nutrition protocol, and
continuous subcutaneous glucose measurements were
performed for 72 h. Normal glucose values were
assumed at ≥2.5 mmol/L (45 mg/dL) and ≤8.3 mmol/L
(150 mg/dL). Frequency, severity and duration of glucose
values beyond normal values were determined.
Results We observed asymptomatic low TG values in
39% of infants in G1 and in 44% in G2. High TG
values were detected in 83% in G1 and 61% in G2.
Infants in G1 experienced prolonged and more severe
low TG episodes, and also more frequent and severe
high TG episodes. In G1 and G2, 87% and 67% of the
infants, respectively, showed glucose fluctuations
characterised by rapid glucose increase followed by a
rapid glucose drop after feeds. In more mature infants,
glucose fluctuations were less pronounced and less
dependent on enteral feeds.
Conclusions Clinically stable well-developing preterm
infants beyond their initial period of intensive care show
interstitial glucose instabilities exceeding values as low
as 2.5 mmol/L and as high as 8.3 mmol/L. This novel
observation may play an important role for the
susceptibility of these high-risk infants for the
development of the metabolic syndrome.
Trial registration number German trial registration
number DRKS00004590.
INTRODUCTION
Hypoglycaemic and hyperglycaemic events in the
first hours, days and weeks of life are associated
with risk factors, such as low gestational age
(LGA), low birth weight, being born small for ges-
tational age (SGA), and maternal conditions, like
pregestational or gestational diabetes among other
conditions both in the neonate and the mother.
Various authors described an incidence of hypo-
glycaemia and hyperglycaemia at different postnatal
ages. Lubchenco and Bard1 reported hypogly-
caemia (<1.7 mmol/L) in 15% of preterm infants
who were appropriate for gestational age and in
67% of infants who were SGA during their first 6 h
of life. Alexandrou et al2 diagnosed hypoglycaemia
(<2.6 mmol/L) in 41% and hyperglycaemia
(>8.3 mmol/L) in 81% of preterm infants during
the first week of life and reported an association of
hyperglycaemia with death and white matter reduc-
tion. Lucas et al3 described hypoglycaemic events
(<2.6 mmol/L) in 39% of infants with birth weight
<1000 g in the first month, which in 10% were
still detected after the fourth week of life.
Previous studies were based on repeated capillary,
arterial or venous glucose measurements, and
usually glucose measurements are frequently per-
formed during the first days of life, successively
reduced and, therefore, only rarely performed once
the infants have reached full enteral nutrition.
In a previous chart analyses, we detected occa-
sional hypoglycaemic episodes in clinically stable
formerly preterm infants fed on a standard bolus-
feed protocol with both enriched breast milk as
well as preterm formula.4 Based on these observa-
tions, we hypothesised that clinically stable very
low birthweight (VLBW) preterm infants are still
What is already known on this topic
▸ Preterm infants are at risk for postnatal
metabolic instability.
▸ Instabilities occur during immediate postnatal
intensive care while on parenteral nutrition.
▸ Both high and low glucose levels are
associated with poor outcome.
What this study adds
▸ This is the first prospective study showing that
metabolic instabilities still occur in very low
birthweight infants at a median-corrected
gestational age of 32 4/7 or 37 days of life.
▸ Metabolic instability remains, especially in
extremely low gestational age infants while
already clinically stable and already on full
enteral nutrition.
▸ Continuous tissue glucose monitoring is able to
identify infants at risk for metabolic instabilities
at a median-corrected gestational age of 32 4/7
or 37 days of life.
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susceptible to developing asymptomatic fluctuations of glucose
levels once on full enteral nutrition. In this prospective study,
we aimed to determine the frequency and severity of tissue
glucose (TG) fluctuations in VLBW infants after having reached
full enteral feeds over a 72 h period using a continuous glucose
monitoring system (CGMS).
PATIENTS AND METHODS
We conducted a prospective observational cohort study
(German trial registration number DRKS00004590) with con-
tinuous subcutaneous glucose monitoring of preterm infants at
the Division of Neonatology, Perinatal Center, LM-University
Munich, Germany, Campus Grosshadern, and at the
Neonatology Department of the Regional Hospital in Bolzano,
Italy. The institutional ethical committees in both hospitals
approved the study, and parental informed consent was obtained
prior to enrolment. Patients were recruited between April 2011
and February 2013 in both centres. Inclusion criteria were (1)
birth weight <1500 g, (2) gestational age <32 weeks post-
menstrual age, (3) on full enteral feeds for at least 5 days and
(4) otherwise clinically stable (no invasive respiratory support,
no signs of infection, no severe desaturation—SpO2 <80%—
and bradycardia heart rate <80/min). Exclusion criteria were (1)
a pathological neonatal metabolic screening test on the third
day of life (DOL) (routine testing in newborns to screen for
certain genetic, metabolic and endocrine disorders), (2) a posi-
tive family history for metabolic diseases, (3) major congenital
malformations and (4) any acute illness requiring intensive care
intervention.
Infants were stratified into two groups according to birth
weight: <1000 g (G1, n=23) and 1000 g—1500 g (G2, n=18),
as we have previously observed occasional low blood glucose
values in formerly preterm infants especially in infants born at
<1000 g.4 Infants at extremes of their gestational age-related
birth weight (SGA, LGA) are at increased risk for glucose
instabilities.1 5–7 Thus, we decided to stratify infants by birth
weight rather than gestational age at birth.
Subcutaneous TG was measured continuously over 72 h with
a standard CGMS (CGMS; Guardian REAL-time, Soft sensor,
Medtronic GmbH, Meerbusch, Germany). The sensor tip was
manually inserted under sterile conditions through the intact
skin in the subcutaneous tissue of the infant’s thigh. It has a
platinum electrode that catalyses interstitial glucose oxidation
and determines average values every 5 min. Results are trans-
ferred wirelessly to a receiver displaying them in real time.
Intermittently, capillary blood samples were analysed with a
‘point of care’ (POC) blood gas analyser (Amperometric glucose
measurement, Radiometer, ABL 700, Copenhagen, Denmark), to
calibrate the subcutaneous sensor. The POC device is regularly
quality insurance tested for three ranges of values: (1) glucose
values <2.5 mmol/L (median 1.6 mmol/L, CI 1.44 to 1.66 mmol/
L), (2) glucose values <6.6 mmol/L (median 5.7 mmol/L, CI 5.40
to 5.58 mmol/L), (3) glucose values >13.9 mmol/L (median
14.2 mmol/L, CI 12.13 to 14.95 mmol/L).
These blood glucose readings were compared with the
values obtained by the CGMS in order to assess the accuracy
of the device. In order to evaluate the accuracy of the CGMS
method, we calculated the correlation between paired glucose
readings from capillary blood samples measured with a POC
blood gas analyser and the corresponding CGMS interstitial
glucose values (R2=0.57, p<0.001; n=307; Pearson’s correl-
ation coefficient; Wilcoxon Signed Rank test). On Bland–
Altman analysis, the mean difference between both monitoring
systems was −0.011 mmol/L (95% CI −0.13 to 0.11, IQR 4.5–
6.1 mmol/L; figure 1). The use of the CGMS has previously
been validated to detect periods of hyperglycaemia and hypo-
glycaemia in preterm infants and in term infants at risk of
glucose fluctuations.8–10 Unfortunately, normal values of CGM
in the neonatal period of healthy term infants are not avail-
able. During the whole study, we did not detect any adverse
effect of CGM in preterm infants, especially, no local or sys-
temic infection associated with the application of the sensor
was observed.
All infants were fed according to a standard bolus-feeding
protocol where full enteral nutrition was provided at
150–180 mL/kg/day with fortified breast milk or preterm
formula at 110–135 kcal/kg/day two, three or four hourly
depending on the age, and the tolerance of the intakes. The
feeding protocol was according to the recommendations of the
European Society for Paediatric Gastroenterology, Hepatology
and Nutrition Committee on Nutrition for preterm infants.11
Despite the fact that the plasma glucose concentrations that
define low and high glucose values in newborns are without
rigorous scientific justification,12–15 16 we adopted thresholds
for low TG values (≤2.5 mmol/L; ≤45 mg/dL) and high TG
values by two cut-off levels, (>8.3 mmol/L; >150 mg/dL and
Figure 1 Bland–Altman Plot,
continuous glucose monitoring system
(CGMS) versus point of care (ABL).
Horizontal axis represents the mean of
the sensor (CGMS) and point-of-care
glucose measurement (mmol/L). Vertical
axis represents the difference between
the sensor (CGMS) and the point-of-care
glucose measure (mmol/L). Solid lines
indicate ±2SD.
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>11.1 mmol/L; >200 mg/dL) in accordance with previous
studies on blood glucose.2 17–19
The variability of TG was calculated as the SD of TG values
per infant throughout the study period (TG-SD).20 21 In order
to identify possible risk factors associated with high-amplitude
TG fluctuations, we correlated individual SD values with poten-
tial risk factors for glucose instability: gestational age at birth
and at trial entry, nutritional components like total fluids, carbo-
hydrates, protein and lipids, as well as total days on parenteral
nutrition prior to CGM. Additionally, the Clinical Risk Index
for Babies (CRIB-Score) and the Body Mass Index (BMI) at
birth were calculated and evaluated. The CRIB score is a com-
posite score for preterm infants born at <1500 g, derived from
birth weight, gestational age, lowest base excess, minimal and
maximal FiO2 within the first 12 h of life and malformations.
Thus, a high CRIB-score is an indicator for poor outcome.22
Data were analysed using the Statistical Package for Social
Sciences V.20.0 (SPSS, Chicago, Illinois, USA).
Statistical analysis within cohorts was carried out with χ2 tests
to rule out any effect of confounding factors. For the calculation
of significance levels across cohorts, non-parametric Mann–
Whitney U test or a Kruskal Wallis test was used. Since many of
the variables were not distributed normally, the median and
IQRs for both cohorts were calculated and are the main mea-
sures reported. Risk factors were correlated to TG-SD by
Pearson’s correlation. Further analysis of these factors was
achieved by stepwise linear regression analysis. The level of sig-
nificance was set at p<0.05.
RESULTS
Table 1 displays demographics and characteristics of infants
enrolled in both strata at birth and at trial entry. The infants in
both groups were enrolled at a median-corrected postmenstrual
age of 37 DOL (IQR: 31 DOL–48 DOL) and a median-
corrected gestational age of 33 weeks (IQR: 31 3/7–34 3/7).
TG values obtained with the CGMS showed cyclic fluctua-
tions exceeding 2.5 mmol/L and 8.3 mmol/L throughout the
day. Typically, high TG peaks were followed by rapid drops con-
comitant with the feeding schedule. These fluctuations occurred
regardless of whether the infant was fed two, three or four
hourly. By contrast, TG fluctuations were less pronounced and
remained within the predefined range in G2, despite the fact
that both groups were approximately 33 weeks corrected post-
menstrual age at trial entry (median—IQR: 31 3/7–34 3/7). The
majority of infants (75%) were fed three hourly. In figure 2, the
combined measurements of all these infants is outlined as mean
±2SDs, with the grey area indicating the presumed normal
range of 2.5–8.3 mmol/L (figure 2).
TG values fluctuated beyond the predefined limits in 20/23
(87%) infants in G1 and 12/18 (67%) infants in G2. Only nine
of the 41 enrolled infants (22%, 3/23 in G1 and 6/18 in G2)
had stable TG values within the normal range throughout the
entire study period (table 2).
Of all infants, 12% showed at least one episode of low TG,
37% had at least one episode of high TG and 29% suffered
both low and high TG throughout the monitored time. The
occurrence of low TG was similar in both groups (39% in G1
and 44% in G2), whereas high TG was more frequent in G1
(83%) compared with G2 (61%, table 2).
In G1, 1/23 (4%) infants had very low TG (<1.7 mmol/L/
31 mg/dL) and 8/23 (35%) values between 1.7 and 2.5 mmol/L
(31–45 mg/dL). In G2, 8/18 (44%) presented TG values
<2.5 mmol/L (<45 mg/dL), whereas no infant developed values
below 1.7 mmol/L (31 mg/dL). Considering the high TG thresh-
old >8.3 mmol/L (150 mg/dL), 8/23 (35%) in G1 and 9/18
(50%) in G2 developed recurrent high TG episodes. A TG value
above 11.1 mmol/L (200 mg/dL) was observed in 11/23 (48%)
infants in G1 and 2/18 (11%) in G2 (table 2 and figure 3A–C).
Figure 3C illustrates the duration and severity of all 402
recorded low and high TG episodes.
Of the registered 38 episodes of low TG values among all
infants, 12/38 (32%) lasted <10 min, 12/38 (32%) lasted
10–30 min, 9/38 (24%) lasted 30–60 min and 5/38 (13%) lasted
>60 min. Seventeen patients had hypoglycaemic episodes during
the 72 h monitoring. Of these 17 patients, 10 (59%) had only
one hypoglycaemic episode and seven (41%) had more than one
hypoglycaemic episodes. Of the infants with recurrent hypogly-
caemic episodes, four were in G1 and three belonged in G2.
Table 1 Infants’ characteristics (median—IQRs)
BW <1000 g BW 1000–1500 g
Baseline
Number 23 18
Gestational age (weeks) 25 5/7 (24 1/7–27) 29 6/7 (28 5/7–30 3/7)
Birth weight (g) 672.5 (615–900) 1210.0 (1152.5–1327.5)
BMI 6.8 (6.3–7.3) 7.7 (7.1–8.4)
SGA (%) 17 11
Male (%) 65 72
Antenatal glucocorticoids (%) 91 100
Caesarean section (%) 87 89
CRIB score 7 (2–8) 1 (1–1.25)
At study entry
Day of life 47.0 (38–53) 31.0 (26–36)
Gestational age (weeks) 32 2/7 (30 4/7–33 5/7) 33 5/7 (32 5/7–34 6/7)
Weight (g) 1350.0 (1246.25–1510) 1650.0 (1570–1805)
Length (cm) 39.0 (36.0–41.0) 41.8 (41–42.6)
Head circumference (cm) 27.0 (25.5–29.0) 28.8 (28.0–29.9)
Total length of parenteral nutrition (days) 17 (12–23) 12 (9–13)
Days after end of total parenteral nutrition 28 (18–43) 19 (15–23)
BMI, Body Mass Index; CRIB, Clinical Risk Index for Babies; SGA, small for gestational age; BW, birth weight.
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A total of 305 episodes with high glucose values between 8.3
and 11.1 mmol/L were recorded. Of those, 13 (4%) lasted
<10 min, 174 (57%) lasted 10–30 min, 67 (22%) lasted 30–60
min and 51 (17%) lasted >60 min. Of the 59 episodes of severe
high TG episodes (>11.1 mmol/L), 2 (3%) lasted <10 min, 32
(54%) between 10 min and 30 min, 12 (38%) lasted 30–60 min
and 13 (22%) lasted >60 min (figure 3D).
TG-SDs were negatively correlated with the gestational age at
birth (R=−0.43; 95% CI −0.64 to −0.06), the gestational age
at study entry (R=−0.42; 95% CI −0.64 to −0.15), the BMI at
birth (R=−0.32; 95% CI −0.53 to −0.06), and positively corre-
lated with the total days on parenteral nutrition (R=0.56; 95%
CI 0.21 to 0.74), as well as the CRIB-score at birth (R=0.43;
95% CI 0.11 to 0.61). In the linear regression model, only the
number of days on total parenteral nutrition remained a signifi-
cant risk factor for TG fluctuations (p=0.02) and the gestational
age at study entry just missed significance (p=0.07). Nutritional
components, total fluids and BMI at birth had no effect on
TG-SD. TG variability was not related to gender, mode of deliv-
ery, bronchopulmonary dysplasia, IVH (intraventricular haemor-
rhage) and periventricular leukomalacia. We could not detect
any significant difference in weight gain 7 days before and after
the monitoring period, either among cohorts or when trying to
relate them to low or high glucose events. However, the nine
infants in this study (3/23 in G1 and 6/18 in G2) with glucose
values within the predefined glucose range of 2.5–8.3 mmol/L
showed a significantly better weight gain than unstable ones
(p=0.046).
DISCUSSION
In this study, we report for the first time glucose instabilities in
preterm infants after their initial postnatal period of intensive
care. The infants in our study were clinically stable on full
enteral bolus nutrition without any potential reason for glucose
fluctuations beyond normal limits. In general, clinically stable
preterm infants are assumed to be also metabolically stable as
soon as blood glucose measurements have repeatedly returned
values within a normal range. As a result, further blood glucose
measurements are normally not routinely performed.18 23 To
date, we are not able to conclude whether our novel findings on
TG are worrisome, because there are no normal TG values
available for preterm infants. However, several authors reported
that repeated episodes of hypoglycaemia with values
<2.6 mmol/L in the early postnatal period, both symptomatic
and asymptomatic, impair neurodevelopment.3 24–26
Hypoglycaemia is associated with reduced brain growth and
neonatal brain injury.24 27–29 Additionally, hyperglycaemia in
the first week of life has been described as a risk factor asso-
ciated with death, severe IVH and white matter reduction.2 19
Alexandrou et al2 reported that only 10 of 113 infants born
at <27 weeks gestational age maintained a normoglycemic level
in the first week of life. We performed glucose measurements
between the third and eighth week of life and registered 38 epi-
sodes of low glucose episodes, 305 of moderately high glucose
episodes (>8.3 mmol/L–150 mg/dL) and 59 events of severely
elevated levels with TG levels >11.3 mmol/L/200 mg/dL. After
the first 10 DOL, frequent glucose measurements are not con-
sidered to be needed in clinically stable infants without risk
factors, especially after reaching full enteral feeds.12 30 The high
incidence of high and low glucose levels detected in this study
by CGMS demonstrates for the first time that this assumption
does not hold true for former VLBW infants. These prospective
data confirm our previous retrospective chart analysis.4 For
VLBW infants, the difficulty to maintain their systemic glucose
level within a normal range seems to continue even after the
first month of life, despite clinical stability and full enteral nutri-
tion according to current nutritional guidelines.11
Figure 2 Cumulated tissue glucose
(TG) tracings from all infants on 3-hourly
bolus feeds (eight feedings per day,
n=31). Black line indicates mean tissue
glucose within 24 h; grey lines indicate
2SD TG values indicating meal-
associated fluctuations. Grey area
outlines the normal range
>2.5 mmol/L–≤8.3 mmol/L.
Table 2 Results
BW <1000 g BW 1000–1500 g
Number 23 18
Infants with tissue glucose fluctuations 87% (20) 67% (12)
Stable infants 13% (3) 33% (6)
Incidence of low tissue glucose values 39% 44%
Tissue glucose values <1.7 mmol/L 4% (1) –
Tissue glucose values 1.7–2.5 mmol/L 35% (8) 44% (8)
Incidence of high tissue glucose values 83% 61%
Tissue glucose values >8.3 mmol/L 35% (8) 50% (9)
Tissue glucose values >11.1 mmol/L 48% (11) 11% (2)
BW, birth weight.
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All the 402 registered low and high glucose episodes in this
study were asymptomatic. This finding is of major concern, as
both extremes have been demonstrated previously to potentially
harm these infants.3 21 22 24 25 27
By using CGMS, we were able to assess the duration of glucose
values beyond the normal range. Almost one quarter of the low
glucose episodes lasted between 30 and 60 min, whereas the
more frequent high glucose episodes lasted usually between 10
and 30 min, and in 17% >60 min. It is quite worrying that
VLBW infants show high glucose levels at this age, since the same
glucose values in the first week of life are associated with
increased mortality and white matter reduction.2 Additionally,
we registered episodes of high TG, of which 54% lasted 10–
30 min, 20% between 30 and 60 min and 22% longer than
60 min. Several follow-up studies have shown that previously
preterm infants are at risk for intima thickening of vessels and for
the development of metabolic syndrome later in life.31–33 Our
data might provide the link between these findings and the cause
of future sequelae of extremely preterm infants as we find espe-
cially high prevalence of high TG in these infants.
A weakness of our study is the low sample size. Nevertheless,
the variability of TG (TG-SD) in our two cohorts decreases with
increased gestational age at birth, a higher BMI at birth as well as
with increased postmenstrual age at the time of measurements.
And the duration of parenteral nutrition, typically shorter in more
mature infants, remained significant in the linear regression model.
Despite not reaching significance in the regression model, all
our data point to prematurity per se being the major risk factor
for glucose instabilities after birth. It has been shown in the past
that metabolic adaptation in preterm infants differs from infants
born at term. Immature neonates (24–29 weeks gestational age
and birth weight between 600 and 1200 g) can produce glucose
via glycogenolysis and gluconeogenesis at rates comparable with
term newborns during their first DOL, but the functional imma-
turity of the enzymatic systems increases the propensity to hypo-
glycaemic episodes.18 34 35 During the first postnatal week, the
relation between glucose and other energy sources in preterm
infants are low because they cannot sustain gluconeogenesis at
the same rate as term newborns. The accumulation of glycogen,
fat and protein occurs only in the last 8 weeks of pregnancy,
and since VLBW infants are born substantially earlier, they are
not able to tolerate long periods of fasting.18 34 Blood glucose
values have been shown to vary more in preterm infants after
birth. On one hand, the immaturity of the glucose sensor in the
pancreatic β cell leads to an inability to downregulate insulin
secretion during hypoglycaemia. On the other hand, the hepato-
cyte response to the circulating insulin concentrations during
hyperglycaemia is immature as well, instead continuing with
their glucose production.17
The relative lack of adipose tissue (<2% of total body
weight) and glycogen stores in this group of neonates results in
an incapability of producing alternative fuels to maintain eugly-
caemia via glycogenolysis and gluconeogenesis for long periods
of fast, causing a limitation for protective metabolic counter-
regulation during hypoglycaemia.18 In preterm infants, the
endocrine and enzyme control of intermediate metabolism is
Figure 3 (A–D) Frequency (% of infants in cohort) of low (A) and high (B) tissue glucose (TG) episodes with regard to severity in both weight
cohorts. (C) Overall frequency (% of infants in cohort) of abnormal TG. (D) Duration and severity of all recorded episodes.
F130 Mola-Schenzle E, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F126–F131. doi:10.1136/archdischild-2014-306168
Original article
group.bmj.com on May 3, 2017 - Published by http://fn.bmj.com/Downloaded from 
immature and not fully developed, leading to a failed homeosta-
sis. They are less able than term infants to adapt to cessation of
intrauterine nutrition, and they depend partly on total parental
nutrition during the first weeks of life.17 34 36 37
Preterm infants also have lower ketone body concentrations,
even at lower glucose values, than term infants.36
Glucose-regulated insulin secretion (first detected at the 11th
week of gestation, but not released until the 20th week) by the
pancreatic β cell is still immature in preterm infants, resulting in
unregulated and inadequate insulin production and secretion.
The plasma insulin concentration and the insulin/glucose ratio
increase exponentially with gestation, indicating the maturation
of the pancreas.18 35 In our study, insulin secretion was not
determined due to ethical reasons. TG values determined by
CGM measurements very well represent blood glucose values
even in preterm infants.38 However, TG values change mirror
glucose values with a substantial time delay of about 20 min.
Thus, repeated blood samples would have been necessary to
actually determine corresponding blood insulin levels. However,
we speculate that immature glucose metabolism at the time of
our measurements is responsible for glucose derailments
detected in this study. The preterm organism is, most likely, not
yet equipped to deal with repeated high caloric bolus nutrition,
a usual practice in neonatal intensive care units today.18 23 36 37
Current feeding practices for preterm neonates involve small
bolus meals, for example, every 2–4 h.
CONCLUSION
The incidence of low and high glucose episodes without any
clinical signs in stable, fully enteral-fed preterm infants is high.
This is the first study to describe glucose instability in these
infants, and prematurity may be a key factor for this phenom-
enon. Whether breast milk fortification is responsible and
whether persisting glucose fluctuations in preterm infants have a
long-term effect with regard to somatic and neurological devel-
opment in these infants require further studies.
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